Eleni Frangou

8PUBLICATIONS
63CO-AUTHORS
Planning and decision makingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillanceMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 26, 2026
PROTEUS: A Prospective RCT Evaluating Use of AI in Stress Echocardiography.

|Sep 21, 2026
Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.

|Apr 16, 2026
Multiplexed P21/MCM-2 Detection Predicts Relapse and May Identify Tyrosine Kinase Inhibitor-Resistant Patients in Clear Cell Renal Cell Carcinoma.

|Feb 10, 2026
QT prolongation risk factors and a monitoring strategy in rifampicin-resistant tuberculosis: Findings from the STREAM Stage 2 trial.

Gareth Hughes, Elena Frangou, Henry Bern

|Aug 02, 2025
Brain Imaging and Whole Blood Targeted Transcriptomic Analyses to Characterize Cerebral Infarctions in Children With Tuberculous Meningitis.

Julie Huynh, Pieter M Pretorius, Wajanat Jan

|Feb 25, 2022
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.

Bhavna Oza, Tim Eisen, Eleni Frangou

Pageof 2

Frequent Collaborators

3 joint publications

James Larkin

3 joint publications

Grant D Stewart

2 joint publications

Mahesh K B Parmar

2 joint publications

Steven Joniau